tradingkey.logo
搜尋

Canton Strategic Holdings Ord Shs

CNTN
添加自選
1.710USD
-0.090-5.00%
收盤 11-13 16:00(美東)
136.25M總市值
虧損本益比TTM

關於 Canton Strategic Holdings Ord Shs 公司

Tharimmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic candidates for inflammatory and immunologic conditions with unmet need. It has a transmucosal film product, TH104, is a Phase II ready clinical candidate and an oral biologic as well as two bispecific biologics in pre-clinical development. TH104 is a transmucosal buccal film embedded with the active compound nalmefene onto a thin film which adheres inside of the mouth on the cheek and biodegrades. TH104 is an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. It is also developing an early-stage pipeline of novel therapeutic candidates targeting validated high value immune-oncology targets including human epidermal growth factor receptor 2, human EGF receptor 3 and programmed cell death protein. The Company is developing antibodies, including bispecific antibodies, antibody drug conjugates, among others.

Canton Strategic Holdings Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Canton Strategic Holdings Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Mark Toomey
Mr. Mark Toomey
President
President
--
--
Mr. William Wiley
Mr. William Wiley
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
Mr. Rishi Nangalia
Mr. Rishi Nangalia
Independent Director
Independent Director
--
--
,
,
--
--
Mr. Clay Kahler
Mr. Clay Kahler
Independent Director
Independent Director
--
--
Mr. Mark Wendland
Mr. Mark Wendland
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark Toomey
Mr. Mark Toomey
President
President
--
--
Mr. William Wiley
Mr. William Wiley
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
Mr. Rishi Nangalia
Mr. Rishi Nangalia
Independent Director
Independent Director
--
--
,
,
--
--

常見問題

Canton Strategic Holdings Ord Shs的前五大股東是誰?

Canton Strategic Holdings Ord Shs的前五大股東如下: ,
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有